Definitive Healthcare Corp (DH)

Featured in High-Beta Stocks

Definitive Healthcare Corp. is a healthcare technology company listed on NASDAQ under the ticker DH. The company develops a software-as-a-service platform that delivers commercial intelligence for the healthcare sector in the United States and internationally. Its platform is designed to organize information on healthcare providers and their activities, supporting uses such as product development, go-to-market planning, sales and marketing execution, clinical research, strategy, talent acquisition, and physician network management. Definitive Healthcare serves biopharmaceutical and medical device companies, healthcare information technology companies, healthcare providers, and a range of other organizations, including staffing, commercial real estate, financial services, and marketing and advertising firms. Founded in 2011, the company is headquartered in Framingham, Massachusetts.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-DH
$1.21
67.6% Upside
Bargain
$2.20
205.6% Upside
Bargain
Fair
0.0%
August 12, 2026
-0.6x
0.7x
0.4x
103.6 M
112 M
53.4%
33.3%
-3.3
-15.9%
Valuation • Fair Value

Definitive Healthcare Corp (NASDAQ-DH) Fair Value by Valuation Model

Compare the primary fair value estimate for Definitive Healthcare Corp (NASDAQ-DH) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$1.21

Estimated upside of 67.6% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$1.34

Earnings power value estimate.

Comps Fair Value

$1.18

Comparable-company valuation reference.

Analyst Price Target

$2.20

Analysts imply upside of 205.6%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Definitive Healthcare Corp (NASDAQ-DH) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Definitive Healthcare Corp (NASDAQ-DH)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

238.3 M

Current operating scale indicator.

Revenue Forecast

223.1 M

Forward revenue estimate.

EBITDA

37.113 M

Current operating profitability reference.

EBITDA Forecast

56.833 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Definitive Healthcare Corp (NASDAQ-DH) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Definitive Healthcare Corp (NASDAQ-DH)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-4.73

No elevated caution signal from this screen.

Altman Z-Score

-3.3

Lower score that deserves closer risk review.

FCF / Net Income

-15.9%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Definitive Healthcare Corp (NASDAQ-DH). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Definitive Healthcare Corp (NASDAQ-DH)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 12, 2026

Days to Earnings

22

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Definitive Healthcare Corp (NASDAQ-DH), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Definitive Healthcare Corp (NASDAQ-DH) Stock Forecast & Technical Outlook

Review Definitive Healthcare Corp (NASDAQ-DH) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Definitive Healthcare Corp (NASDAQ-DH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Definitive Healthcare Corp (NASDAQ-DH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Definitive Healthcare Corp (NASDAQ-DH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Definitive Healthcare Corp (NASDAQ-DH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Definitive Healthcare Corp (NASDAQ-DH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Definitive Healthcare Corp (NASDAQ-DH)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Definitive Healthcare Corp (NASDAQ-DH) has a Hold consensus, with 1 buy, 5 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 5
Sell 0
FAQ Fast Investor Answers

Definitive Healthcare Corp (NASDAQ-DH) Stock FAQ

Quick answers about Definitive Healthcare Corp (NASDAQ-DH) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$1.21
Estimated upside 67.6%
Valuation Rating
Undervalued
Estimated upside of 67.6%
Analyst Target
$2.20
Implied upside 205.6%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Definitive Healthcare Corp (NASDAQ-DH) is $1.21. This implies an estimated upside of 67.6% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 67.6% versus the current market price.

The available analyst price target for Definitive Healthcare Corp (NASDAQ-DH) is $2.20. The analyst target implies estimated upside of 205.6%.

The current financial health read for Definitive Healthcare Corp (NASDAQ-DH) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Definitive Healthcare Corp (NASDAQ-DH) is August 12, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Definitive Healthcare Corp (NASDAQ-DH) is -0.6x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Definitive Healthcare Corp is 103.6 M.

The current enterprise value listed for Definitive Healthcare Corp is 112 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Definitive Healthcare Corp is NASDAQ-DH, and the stock is listed on NASDAQ.

Definitive Healthcare Corp (NASDAQ-DH) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Definitive Healthcare Corp is 53.4%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Definitive Healthcare Corp is 33.3%. Free float helps investors understand how much of the share base is available for public trading.